COVID-19 Updates | IPharmaCenter

top of page

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

WHO granted EUL to Covaxin; acclaims easy storage requirement

WHO granted EUL to Covaxin; acclaims easy storage requirement

WHO granted EUL to Covaxin; acclaims easy storage requirement

United Kingdom COVID19 News | Has Britain reached herd immunity?

United Kingdom COVID19 News | Has Britain reached herd immunity?

United Kingdom COVID19 News | Has Britain reached herd immunity?

France COVID-19 Updates | COVID-19 News in Europe

France COVID-19 Updates | COVID-19 News in Europe

France COVID-19 Updates | COVID-19 News in Europe

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA extended emergency use authorization of Veklury to all hospitalized patients

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

Gilead’s Veklury received conditional marketing authorization from the European Commission

Janssen’s COVID-19 vaccine trial to begin in second half of July

Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit

Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation

PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE

FACTS ABOUT CHLOROQUINE TREATMENT FOR COVID-19

FACTS ABOUT CHLOROQUINE TREATMENT FOR COVID-19

FACTS ABOUT CHLOROQUINE TREATMENT FOR COVID-19

J&J announces lead vaccine for COVID-19, commits to provide one billion vaccines worldwide

NICE recommendation to manage symptoms of COVID-19

NICE recommendation to manage symptoms of COVID-19

NICE recommendation to manage symptoms of COVID-19

COVID-19 UPDATES

COVID-19 UPDATES

COVID-19 UPDATES

HOW CHINA IS RESPONSIBLE FOR COVID-19 OUTBREAK

HOW CHINA IS RESPONSIBLE FOR COVID-19 OUTBREAK

HOW CHINA IS RESPONSIBLE FOR COVID-19 OUTBREAK

bottom of page